{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:27:26Z","timestamp":1778858846524,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.amjmed.2008.03.023","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T04:36:12Z","timestamp":1212035772000},"page":"S20-S29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S","title":["Initiating and Intensifying Insulin Therapy in Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"121","author":[{"given":"Joseph","family":"Tibaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib2","first-page":"5","article-title":"American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control, 2001","volume":"8","year":"2002","journal-title":"Endocr Pract."},{"issue":"suppl1","key":"10.1016\/j.amjmed.2008.03.023_bib3","first-page":"S4","article-title":"Standards of medical care in diabetes\u20142007","volume":"30","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2008.03.023_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4158\/EP.13.3.260","article-title":"Road maps to achieve glycemic control in type 2 diabetes mellitus [ACE\/AACE Diabetes Recommendations Implementation Conference; AACE Website]","volume":"13","year":"2007","journal-title":"Endocr Pract."},{"key":"10.1016\/j.amjmed.2008.03.023_bib5","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","article-title":"Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study","volume":"28","author":"Peyrot","year":"2005","journal-title":"Diabetes Care"},{"issue":"suppl 3","key":"10.1016\/j.amjmed.2008.03.023_bib6","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.ijo.0802173","article-title":"When oral agents fail: practical barriers to starting insulin","volume":"26","author":"Korytkowski","year":"2002","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.1016\/j.amjmed.2008.03.023_bib7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"Overview of 6 years' therapy of type 2 diabetes: a progressive disease","volume":"44","year":"1995","journal-title":"Diabetesz"},{"key":"10.1016\/j.amjmed.2008.03.023_bib8","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2008.03.023_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1067\/mpd.2001.118887","article-title":"Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)","volume":"139","author":"White","year":"2001","journal-title":"J Pediatr."},{"key":"10.1016\/j.amjmed.2008.03.023_bib10","first-page":"2563","article-title":"Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"15","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2008.03.023_bib11","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","article-title":"Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"290","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2008.03.023_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2008.03.023_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-145-9-200611070-00009","article-title":"Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus","volume":"145","author":"Ceglia","year":"2006","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.amjmed.2008.03.023_bib14","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","article-title":"The Treat-to-Target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients","volume":"26","author":"Riddle","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2008.03.023_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.clinthera.2006.10.020","article-title":"Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes","volume":"28","author":"Philis-Tsimikas","year":"2006","journal-title":"Clin Ther."},{"key":"10.1016\/j.amjmed.2008.03.023_bib16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2337\/dc05-1365","article-title":"A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-na\u00efve people with type 2 diabetes","volume":"29","author":"Hermansen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2008.03.023_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0149-2918(98)80058-1","article-title":"Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe","volume":"20","author":"Graff","year":"1998","journal-title":"Clin Ther."},{"key":"10.1016\/j.amjmed.2008.03.023_bib18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.clinthera.2004.09.009","article-title":"Preference for insulin delivery systems among current insulin users and nonusers","volume":"26","author":"Summers","year":"2004","journal-title":"Clin Ther."},{"key":"10.1016\/j.amjmed.2008.03.023_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00044011-200626070-00001","article-title":"A review of 20 years' experience with the NovoPen family of insulin injection devices","volume":"26","author":"Rex","year":"2006","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.amjmed.2008.03.023_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1463-1326.2005.00492.x","article-title":"Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes","volume":"8","author":"Kvapil","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjmed.2008.03.023_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00129784-200606050-00002","article-title":"Thiazolidinediones in patients with diabetes mellitus and heart failure: implications of emerging data","volume":"6","author":"Macfarlane","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.amjmed.2008.03.023_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-2006-925222","article-title":"Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: an assessment of treatment flexibility","volume":"38","author":"Standl","year":"2006","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.amjmed.2008.03.023_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.arcmed.2005.10.015","article-title":"Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride","volume":"37","author":"Eliaschewitz","year":"2006","journal-title":"Arch Med Res."},{"key":"10.1016\/j.amjmed.2008.03.023_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1463-1326.2005.00563.x","article-title":"Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70\/30 (The 1-2-3 Study)","volume":"8","author":"Garber","year":"2006","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.amjmed.2008.03.023_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diacare.28.2.260","article-title":"Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs","volume":"28","author":"Raskin","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2008.03.023_bib26","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.clinthera.2004.12.015","article-title":"Combined therapy with insulin lispro Mix 75\/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy","volume":"26","author":"Malone","year":"2004","journal-title":"Clin Ther."},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib27","article-title":"Therapeutic effectiveness of two insulin regimens for insulin naive patients with type 2 diabetes mellitus: once-daily basal insulin or twice-daily premixed insulin?","volume":"55","author":"Sun","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.amjmed.2008.03.023_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1464-5491.2005.01511.x","article-title":"Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes","volume":"22","author":"Malone","year":"2005","journal-title":"Diabet Med."},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2008.03.023_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ijo.0802743","article-title":"The pathophysiological basis for intensive insulin replacement","volume":"28","author":"Rolla","year":"2004","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.1016\/j.amjmed.2008.03.023_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-2004-826163","article-title":"Beta- and alpha-cell dysfunction in type 2 diabetes","volume":"36","author":"Del Prato","year":"2004","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.amjmed.2008.03.023_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11892-007-0008-4","article-title":"The role of glucose as an independent cardiovascular risk factor","volume":"7","author":"Middelbeek","year":"2007","journal-title":"Curr Diab Rep."},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4158\/EP.12.S1.42","article-title":"Contributions of fasting and postprandial glucose to hemoglobin A1c","volume":"12","author":"Monnier","year":"2006","journal-title":"Endocr Pract."},{"key":"10.1016\/j.amjmed.2008.03.023_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2006.10.015","article-title":"A review of human and analogue insulin trials","volume":"77","author":"Gough","year":"2007","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.amjmed.2008.03.023_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0140-6736(00)02546-0","article-title":"Insulin glargine","volume":"356","author":"Bolli","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2008.03.023_bib35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1023\/B:PHAM.0000036926.54824.37","article-title":"The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin","volume":"21","author":"Havelund","year":"2004","journal-title":"Pharm Res."},{"key":"10.1016\/j.amjmed.2008.03.023_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1463-1326.2006.00685.x","article-title":"Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes","volume":"9","author":"Klein","year":"2007","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.amjmed.2008.03.023_bib37","doi-asserted-by":"crossref","first-page":"952","DOI":"10.7326\/0003-4819-138-12-200306170-00006","article-title":"Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: a randomized, controlled trial","volume":"138","author":"Fritsche","year":"2003","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.amjmed.2008.03.023_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2003-39080","article-title":"A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes","volume":"35","author":"Massi Benedetti","year":"2003","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.amjmed.2008.03.023_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.29.01.06.dc05-1058","volume":"29","author":"Kennedy","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2008.03.023_bib40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00125-005-0132-0","article-title":"Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study","volume":"49","author":"Yki-Jarvinen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjmed.2008.03.023_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00044011-200727040-00007","article-title":"Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes, and this advantage increases with baseline body mass index","volume":"27","author":"Ra\u0161lov\u00e1","year":"2007","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.amjmed.2008.03.023_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1463-1326.2006.00674.x","volume":"9","author":"Meneghini","year":"2007","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.amjmed.2008.03.023_bib43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/diacare.28.6.1282","article-title":"Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine","volume":"28","author":"Davies","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2008.03.023_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1056-8727(03)00076-X","article-title":"Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70\/30, biphasic human insulin 70\/30, or NPH insulin in combination with metformin","volume":"17","author":"Kilo","year":"2003","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.amjmed.2008.03.023_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diabres.2005.10.024","article-title":"Comparative efficacy of glimepiride and\/or metformin with insulin in type 2 diabetes","volume":"72","author":"Kabadi","year":"2006","journal-title":"Diabetes Res Clin Pract."},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib46","first-page":"A510","article-title":"Adding NovoLog\u00ae Mix 70\/30 once or twice daily is more efficacious than optimizing oral treatment in patients with type 2 diabetes","volume":"54","author":"Wan","year":"2005","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib47","first-page":"487","article-title":"Over 75% of patients with type 2 diabetes reached HbA1c <7% by adding biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment","volume":"49","author":"Raskin","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjmed.2008.03.023_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2310\/6650.2007.06036","article-title":"Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted","volume":"55","author":"Lingvay","year":"2007","journal-title":"J Investig Med."},{"issue":"24","key":"10.1016\/j.amjmed.2008.03.023_bib49","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/BF02877782","article-title":"Biphasic insulin aspart 70\/30 three times a day in older patients with Type 2 diabetes not achieving optimal glycemic control on a twice-daily regimen: A retrospective case series analysis from clinical practice","author":"Tibaldi","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.amjmed.2008.03.023_bib50","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00125-006-0243-2","article-title":"Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes","volume":"49","author":"Luzio","year":"2006","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib51","article-title":"Basal insulin and oral antihyperglycemic therapy (BOT) plus a single dose of insulin glulisine at breakfast or at the predominant meal lower HbA1c in patients with type 2 diabetes","volume":"55","author":"Lankisch","year":"2006","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib52","article-title":"Using a simple algorithm (ALG) to adjust mealtime glulisine (GLU) based on preprandial glucose patterns is a safe and effective alternative to carbohydrate counting (Carb Count)","volume":"55","author":"Bergenstal","year":"2006","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2008.03.023_bib53","first-page":"610","article-title":"The PREFER Study: both biphasic insulin Aspart 30 (BIAsp 30) twice-daily and basal-bolus using insulin detemir (IDet) and insulin aspart (IAsp) enabled patients with type 2 diabetes to achieve A1c target <7.0%","volume":"49","author":"Liebl","year":"2006","journal-title":"Diabetologia"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308003100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308003100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:48:08Z","timestamp":1757580488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934308003100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0002934308003100"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.03.023","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiating and Intensifying Insulin Therapy in Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}